Friday, 26 May 2017

Contract Research News

  • GVK licenses its biomarker database to National Cancer Institute

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: GVK Biosciences, Asia's leading contract research organization (CRO) has licensed its popular clinical biomarker database (GOBIOM) to the prestigious Division of Cancer Preventi...Read more

  • Quintiles signs bioanalytical deal with Korean CRO

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with BioCore, a leading Seoul-based bioanalytical contract research organiza...Read more

  • CROs fertile ground for career growth

    Contract Research |  Opinion | By BioSpectrum Bureau | 0 Comment

            Over the past few years, a significant shift has occurred in the depth and type of relationships that the pharmaceutical industry has with its third party contractors. Fro...Read more

  • Quintiles to acquire Novella Clinical

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Quintiles is all set to acquire US-based Novella Clinical, a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those i...Read more

  • Gregory Dennis is now PPD's VP of product development

    Contract Research |  Influencers | By BioSpectrum Bureau | 0 Comment

    Singapore: Clinical research firm, Pharmaceutical Product Development (PPD), has appointed Mr Gregory Dennis, as VP of global product development. In this role, Dr Dennis serves as therapeu...Read more

  • Australia ideal for early-stage drug development

    Contract Research |  Opinion | By BioSpectrum Bureau | 0 Comment

    Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900s. This history includes a notable sprinkling of Nobel Prize winners,...Read more

  • MedImmune, WuXi form joint venture

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing company, have formed a joint venture to develop and commercialize MEDI...Read more

  • Taiwan recognizes Parexel as best CRO

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Foundation of Medical Professionals Alliance in Taiwan (FMPAT) has recognized contract research firm, PAREXEL, as the 2014 Best Performing CRO in Taiwan. "Parexel applies its sc...Read more

  • AMRI acquires Oso Biopharmaceuticals at $110 mn

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: US based contract research firm, AMRI, with operations in Asia, has acquired Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners and a co...Read more

  • BioCOS rides on established R&D protocols

    Contract Research |  Influencers | By Vipul Murarka | 0 Comment

    The affordable and personalized healthcare has been a major concern worldwide. The big pharma and diagnostic companies are now realizing the strong impact of efficient computational methods...Read more

  • John Crowley is Charles River's CAO

    Contract Research |  Influencers | By BioSpectrum Bureau | 0 Comment

    Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate controller and chief accounting officer (CAO), effective September 30, 2013...Read more

  • Korea drug dev fund joins hands with US CRO

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: WCCT Global announced a mutual cooperation and business agreement with Korea Drug Development Fund (KDDF) located in Seoul, South Korea. This will be only the second global net...Read more

  • Transgene out-licenses TG1042 to Ascend Pharma

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: French biotech firm Transgene SA has granted Ascend Biopharmaceuticals, an emerging privately-held Australian immunotherapy company, a license to develop and commercialize TG1042...Read more

  • Cliantha uses Acceliant software to manage trials

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: India based contract research organization (CRO), Cliantha Research has implemented Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant is the m...Read more

  • Quintiles acquires Novella, retains leadership team

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Global CRO Quintiles has completed the acquisition of Novella Clinical, a full-service clinical research organization focused primarily on emerging oncology customers as well as ...Read more

  • WuXi's Suzhou facility clears FDA inspection

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China's research and development service firm, WuXi PharmaTech has cleared the surveillance Good Laboratory Practice (GLP) inspection by US Food and Drug Administration (FDA) for...Read more

  • Pusey is new president, GM of WuXiPRA China

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and general manager. Dr Pusey has more than 25 years of experience in medi...Read more

  • China clears WuXi PharmaTech toxicology facility

    Contract Research |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Bioscience R&D outsourcing services company WuXi PharmaTech's toxicology facility in Suzhou has received a certificate of Good Laboratory Practice (GLP) from the State Food a...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls